Pricing Log in Create free account
Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, West Pharmaceutical Services, Inc. (WST) trades at a price to free cash flow of 62.6×. Over the past ten years it has ranged from 35.9× (February 2026) to 137× (January 2017); the current reading is higher than 53% of that period. That is above the Medical Instruments & Supplies industry median of 25.2× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 42.8× (51.24%)
FY2024 87.7× 39.05%
FY2023 63.1× 57.56%
FY2022 40.0× (62.50%)
FY2021 107× 50.09%
FY2020 71.1× 53.42%
FY2019 46.4× 16.24%
FY2018 39.9× (29.36%)
FY2017 56.5× (57.02%)
FY2016 131× 137.89%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 58.7× 47.71%
Mar 2026 39.7× (7.11%)
Dec 2025 42.8× (15.25%)
Sep 2025 50.5× 8.68%
42 more quarters

Against its own ten years

Low 35.9× High 137×
Ten-year median 61.5×
Current reading's percentile 53

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
MDLN Medline Inc. compare 13.4×
BAX Baxter International Inc. compare 16.1×
BDX Becton, Dickinson and Company compare 16.5×
COO The Cooper Companies, Inc. compare 16.5×
ALC Alcon compare 20.2×
RMD ResMed Inc. compare 21.4×
WST West Pharmaceutical Services, Inc. 62.6×
RGEN Repligen Corporation compare 162×
Medical Instruments & Supplies industry median 25.2×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on WST